Bellevue Group’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$1.73M Hold
75,700
– – 0.1% 113
2018
Q4
$1.52M Hold
75,700
– – 0.1% 102
2018
Q3
$1.65M Hold
75,700
– – 0.1% 109
2018
Q2
$1.68M Sell
75,700
-26,000
-26% -$531K 0.14% 96
2018
Q1
$1.75M Hold
101,700
– – 0.17% 85
2017
Q4
$1.69M Hold
101,700
– – 0.18% 88
2017
Q3
$1.74M Hold
101,700
– – 0.18% 87
2017
Q2
$1.65M Hold
101,700
– – 0.2% 88
2017
Q1
$1.76M Hold
101,700
– – 0.24% 82
2016
Q4
$1.72M Sell
101,700
-28,300
-22% -$472K 0.35% 69
2016
Q3
$2.28M Sell
130,000
-21,400
-14% -$347K 0.41% 69
2016
Q2
$2.18M Hold
151,400
– – 0.41% 70
2016
Q1
$1.86M Hold
151,400
– – 0.34% 80

Other funds holding ANGO

Bellevue Group's ANGO Position: Q1 2019 in Review

Bellevue Group held its AngioDynamics (ANGO) position steady in Q1 2019 at 75,700 shares worth $1.73M. The position accounts for 0.1% of the portfolio, ranked #113.

Bellevue Group first reported a position in ANGO in Q1 2016 and has held it in 13 quarters since. The position peaked at $2.28M in Q3 2016. 178 funds tracked by Wall St. Rank hold ANGO as of Q1 2019.

  • Bellevue Group held 75,700 shares of AngioDynamics worth $1.73M as of Q1 2019.
  • Bellevue Group left its AngioDynamics share count unchanged in Q1 2019.
  • AngioDynamics made up 0.1% of Bellevue Group's portfolio in Q1 2019, its #113 holding.
  • Bellevue Group first reported a position in AngioDynamics in Q1 2016 and has held it in 13 quarters since.
  • Bellevue Group's AngioDynamics position peaked at $2.28M in Q3 2016.
  • 178 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2019.

Based on Bellevue Group's 13F filing for Q1 2019, filed 15 May 2019.